Al's Comment:

 This project will hopefully allow the researcher to apply for a large NIH grant to get the clinical trial going!

I thank all of our end of year donors for making this possible.

We have 3 other worthy projects waiting for funding. If you would like to help fund them, make a donation at:  Virtualtrials.com

As a reminder, the tax laws have changed significantly for next year.  For most people, it is going to be better to donate in 2017 than 2018.  Ask your accountant! As always, it is best to donate appreciated stocks than to donate cash. This works best for stock that you own for over a year.  Click HERE for details on why it is better.  We make it simple to donate stock. Just call us at 888-295-4740 and we will explain how to do it.


Posted on: 12/23/2017

Hewlett, NY 12/23/2017 - The Musella Foundation announced that it has awarded a $10,000 grant to Dr. Srendi at Ann and Robert H. Lurie Children's Hospital of Chicago for the project "Qualification of the PLK4 inhibitor CFI-400945 for future clinical trials on pediatric brain tumors: moving from the bench to the bedside".  She is getting close to human trials. We funded the her earlier work on this topic, which resulted in proof of principle that the approach works.  See http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=22704&author-preview=hio
For details!
 
 
The Musella Foundation would like to thank our donors for allowing us to fund promising research like this! 
 
Happy Holidays!
 
Al Musella, DPM
President
Musella Foundation
 

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!